Top search result for "Filspari" in Treatments. To see all results and access other features, sign up for free.

Filspari (Sparsentan)

Overview
Filspari, approved by the U.S. Food and Drug Administration (FDA) in 2023, is prescribed to slow kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN), a condition characterized by…

MyKidneyDiseaseTeam is the social network for those living with rare kidney diseases. Get the emotional support you need from others like you, and gain practical advice and insights on managing treatment or therapies for kidney disease. MyKidneyDiseaseTeam is the only social network where you can truly connect, make real friendships, and share daily ups and downs in a judgement-free place.

MyKidneyDiseaseTeam is not a medical referral site and does not recommend or endorse any particular provider or medical treatment. No information on MyKidneyDiseaseTeam should be construed as medical and/or health advice.

Your Privacy is Our Priority

Connect with others who understand.

Top search result for "Filspari" in Treatments. To see all results and access other features, sign up for free.

Filspari (Sparsentan)